49 results
8-K
EX-99.1
ALGS
Aligos Therapeutics Inc
12 Mar 24
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
4:06pm
of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this press release that are not historical facts may be considered “forward
SC TO-I
EX-99
ALGS
Aligos Therapeutics Inc
30 Jan 24
Issuer tender offer statement
7:04am
or changes in our expectations, except as required by applicable law.
The safe harbor provided in the Private Securities Litigation Reform Act of 1995
424B3
ALGS
Aligos Therapeutics Inc
28 Nov 23
Prospectus supplement
4:01pm
relative to other forums and protection against the burdens of multi-forum litigation. However, these provisions may have the effect of discouraging
8-K
EX-99.1
rtgp63m
2 Nov 23
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results
4:05pm
8-K
EX-10.1
z4w1z78tgtaac
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-99.1
7ulojdps vi
3 Aug 23
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2023 Financial Results
4:05pm
8-K
3771jzq53 xz52
1 Aug 23
Other Events
4:52pm
8-K
EX-99.1
k2s7n4yqnnn0 z4b
4 May 23
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2023 Financial Results
4:05pm
8-K
EX-99.1
7wwy5kx c5
2 Nov 22
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2022 Financial Results
4:05pm
8-K
EX-99.1
qmzgfobpwbe8yo1lwdk
4 Aug 22
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
vzka03h7c
4 May 22
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2022 Financial Results
4:06pm
8-K
57iu kqtli
22 Mar 22
Other Events
8:23am